Navigation Links
Jazz Pharmaceuticals Announces First Quarter 2011 Financial Results
Date:5/3/2011

million for the first quarter of 2010, reflecting lower product development spending.Interest expense for the first quarter of 2011 was $0.8 million, compared to $5.8 million for the prior year period.  As of March 31, 2011, cash and cash equivalents were $65.1 million, an increase of 45 percent from $44.8 million at December 31, 2010.

Pipeline DevelopmentsJazz Pharmaceuticals is also providing an update on its JZP-6 and JZP-8 development programs:

  • The company has decided that it will not proceed with the additional clinical studies to support the development of JZP-6 (sodium oxybate) in fibromyalgia requested by the Food and Drug Administration (FDA) in its October 2010 complete response letter.  This decision follows an internal analysis of the cost, development time and likelihood of regulatory success associated with further clinical development.
  • Given the estimated costs, development timeline and competitive environment for JZP-8 (intranasal clonazepam), the company is reevaluating whether or how to proceed with additional development.  

  • 2011 Financial Guidance Jazz Pharmaceuticals is providing updated full year 2011 financial guidance as follows:- Total product sales

    $ 237 - 250 million - Xyrem

    $ 205 – 215 million- Luvox CR

    $ 32 – 35 million- Gross margin

    greater than 90%- R&D and SG&A combined expenses

    $ 105 – 110 million- GAAP net income per diluted share

    $ 2.50 – 2.66- Adjusted net income per diluted share*

    $ 2.95 – 3.10 *  A reconciliation of GAAP net income to adjusted net income and the related per diluted share amounts is included with this press release.Conference Call DetailsJazz Pharmaceuticals will host an investor conference call and live audio webcast today at 1:30 p.m. PT/4:30 p.m. ET to provide a business update and discuss 2011 first quarter results and updated 2011 financial guidance.  The liv
    '/>"/>

    SOURCE Jazz Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
    2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
    3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
    4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
    5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
    6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
    7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
    8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
    9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
    10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
    11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/28/2015)... 28, 2015 Research and ... the "Investigation Report on China,s Tobramycin Market, 2010-2019" ... a traditional antibiotic whose eye drop and ointment are ... potential infection or inflammation caused by eye infection. Currently, ... are able to produce tobramycin, among which the Top ...
    (Date:8/28/2015)... Research and Markets ... the "Investigation Report on China,s Latanoprost Market, ... Developed by Pharmacia & Upjohn in 1995, latanoprost ... reduces intraocular pressure. As the first pressure- lowering ... name of Xalatan) entered China ...
    (Date:8/28/2015)... 2015  Perrigo Company plc ("Perrigo") (NYSE: PRGO ... acquisition of leading OTC brands from GSK in an ... is a clear demonstration of Perrigo,s unique ability to ... network spanning 36 countries.  Perrigo Chairman, ... "We are excited to complete this transaction, which clearly ...
    Breaking Medicine Technology:Investigation Report on China's Tobramycin Market, 2015-2019 2China Latanoprost Market Investigation Report 2015-2019 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 3Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 4
    ... Inc. (OTC Bulletin Board: HSPO ), a ... oral thin film products that deliver pharmaceutical and OTC ... has signed a Letter of Intent (LOI) to acquire ... LLC.  HealthSport,s acquisition includes the lease of the 50,000 ...
    ... March 30, 2011 Regado Biosciences, a privately held ... control agents, announced that David J. Mazzo, PhD, President ... Company,s 10th Annual Healthcare Conference at the New York ... 6, 2011 at 11:20 a.m. EDT.  The presentation will ...
    Cached Medicine Technology:HealthSport Signs Letter of Intent to Acquire "Excellent" Rated cGMP Certified Nutraceutical Manufacturing Plant 2HealthSport Signs Letter of Intent to Acquire "Excellent" Rated cGMP Certified Nutraceutical Manufacturing Plant 3Regado Biosciences to Present at the Needham & Company's 10th Annual Healthcare Conference in New York City 2Regado Biosciences to Present at the Needham & Company's 10th Annual Healthcare Conference in New York City 3
    (Date:8/31/2015)... ... August 31, 2015 , ... “My mother and husband use oxygen therapy ... Ky. “I thought there could be a comfortable way to prevent the irritation, so ... Ear Protector offers a more secure way to anchor the cannula tubing used in ...
    (Date:8/31/2015)... ... August 31, 2015 , ... For 12 years, since 2004, the Mesothelioma ... Mesothelioma Awareness Day . On this day, and in the weeks leading up ... involved and helping the cause. , “One of the ways a person can be ...
    (Date:8/31/2015)... TX (PRWEB) , ... August 31, 2015 , ... ... serving communities in and around Grand Prairie, is teaming up with the Tarrant ... throughout the area. , Meals on Wheels is the oldest and largest national ...
    (Date:8/31/2015)... ... August 31, 2015 , ... The Workgroup for ... of health IT to create efficiencies in healthcare information exchange, announces the agenda ... place at the Hyatt Regency Reston in Reston, Va. from October 26-29, WEDI-Con ...
    (Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... Juvent Sports ... growing list of major sports figures who are finding joint pain relief after using ... former #1 men’s tennis player in the world said, “For the first time in ...
    Breaking Medicine News(10 mins):Health News:InventHelp® Inventor Designs Nasal Cannula Ear Protector (AVZ-1217) 2Health News:Cancer Research Organization Paints the World in Mesothelioma Awareness 2Health News:Cancer Research Organization Paints the World in Mesothelioma Awareness 3Health News:Westchester Insurance and the Meals on Wheels Association Announce Joint Charity Effort to Provide Nutritious Meals for Senior Citizens 2Health News:Westchester Insurance and the Meals on Wheels Association Announce Joint Charity Effort to Provide Nutritious Meals for Senior Citizens 3Health News:WEDI Announces Program for Annual Fall Conference: WEDI-Con 2015 2Health News:WEDI Announces Program for Annual Fall Conference: WEDI-Con 2015 3Health News:Mats Wilander, 7 Grand Slam Title Winner and Tennis Legend, Now Plays Without Joint Pain 2Health News:Mats Wilander, 7 Grand Slam Title Winner and Tennis Legend, Now Plays Without Joint Pain 3
    ... right, exercised lowered chances of cardiovascular trouble , TUESDAY, July ... the right foods, exercising and losing weight pay off in ... show. , The reports, both originating at Brigham and Women,s ... of the Journal of the American Medical Association , ...
    ... Clarian/IUSM ... ... 2009 -- Nine clinical programs at Clarian Health / Indiana University School of ... World Report,s "2009-10 America,s Best Hospitals" guide. Clarian,s Methodist Hospital and Indiana University Hospital ...
    ... of the disease , TUESDAY, July 21 (HealthDay News) -- ... figured what genes turn on and off in a person,s ... infection. , The work, done on children with severe ... lead to better treatments for these diseases, including the methicillin-resistant ...
    ... , OWINGS MILLS, Md., July 21 ... program, today announced the launch of Honey Mustard Pretzel Sticks and ... Puffs. The new pretzel sticks and cheese puffs add to the ... while also maintaining the nutritional value of Medifast Meals. The pretzel ...
    ... OAKLAND, Calif., July 21 Stress is a natural part of ... crises, and other seemingly endless things, individuals are experiencing heightened anxiety. ... lessen their intense emotions. However, a number of eating patterns that ... , , Here are some common ...
    ... NEW YORK (July 21, 2009) Columbia University Medical ... the field of schizophrenia, has been selected by the ... Institutes of Health as principal investigator of a nationwide ... treating people experiencing a first episode of the psychotic ...
    Cached Medicine News:Health News:Studies Affirm Value of Healthy Lifestyle 2Health News:Studies Affirm Value of Healthy Lifestyle 3Health News:Clarian Health/Indiana University School of Medicine Specialty Programs Ranked Among Best in Nation 2Health News:Clarian Health/Indiana University School of Medicine Specialty Programs Ranked Among Best in Nation 3Health News:Immune System Gene Discovery Sheds Light on Staph Infections 2Health News:Medifast Adds Pretzel and Puffs to Meal Replacement Line 2Health News:Medifast Adds Pretzel and Puffs to Meal Replacement Line 3Health News:Five Eating Patterns That Worsen Stress 2Health News:Five Eating Patterns That Worsen Stress 3Health News:Columbia leads national effort to develop early intervention for schizophrenia 2Health News:Columbia leads national effort to develop early intervention for schizophrenia 3
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    Medicine Products: